Advanced NMR reports higher 1994 sales
Specialty MRI developer Advanced NMR of Wilmington, MA, reported sales up sharply for1994 (end-December). The company had revenues for the year of$5.3 million, up 173% compared to $1.9 million the year before. Advanced NMR nearly cut its net loss for
Specialty MRI developer Advanced NMR of Wilmington, MA, reported sales up sharply for1994 (end-December). The company had revenues for the year of$5.3 million, up 173% compared to $1.9 million the year before.
Advanced NMR nearly cut its net loss for the year in half.Including its share of losses from its majority-owned AdvancedMammography Systems subsidiary, the company posted a net lossof $3.5 million, down from a $6.2 million net loss in 1993.
Advanced NMR said it expects to see significant revenue in1995 from its InstaScan echo-planar imaging retrofit package,as well as from sales of 3-tesla and 4-tesla MRI systems (SCAN6/1/94). In addition, sales from the Aurora scanner developedby Advanced Mammography Systems are expected to begin in 1995(SCAN 3/15/95).
Advanced NMR reported this month that it sold two InstaScansystems, bringing to 24 the total number of systems installedat clinics.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
